Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors

NCT00777504 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT00777504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00777504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors
Lead sponsor
Radboud University Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2008
Completion date
April 30, 2012
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal stromal tumor, renal cell carcinoma